In the Supreme Court of the United States, U.S. Food & Drug Administration, et al., petitioners, v. Alliance for Hippocratic Medicine, et al., respondents ; Danco Laboratories, L.L.C., petitioner, v. Alliance for Hippocratic Medicine, et al., respondents : on writs of certiorari to the United States Court of Appeals for the Fifth Circuit : brief of 237 reproductive heath, rights, and justice organizations as amici curiae in support of petitioners / Lindsay C. Harrison, counsel of record, Peggy Xu, counsel for amici curiae
- Author
- Harrison, Lindsay C.
- Additional Titles
- U.S. Food & Drug Administration, et al., petitioners, v. Alliance for Hippocratic Medicine, et al., respondents, Danco Laboratories, L.L.C., petitioner, v. Alliance for Hippocratic Medicine, et al., respondents, and HeinOnline index title: Brief amici curiae of 237 reproductive heath, rights, and justice organizations
- Published
- [United States] : [publisher not identified], [2024]
[Getzville, New York] : William S. Hein & Company, [2024] - Physical Description
- 1 online resource (xii, 25, A9 pages).
- Additional Creators
- Xu, Peggy, United States. Food and Drug Administration, Danco Laboratories, L.L.C., Alliance for Hippocratic Medicine, United States. Supreme Court, and United States. Court of Appeals (5th Circuit)
Access Online
- HeinOnline Women and the Law: ezaccess.libraries.psu.edu
- Series
- Summary
- This case concerns mifepristone, a drug that the U.S. Food and Drug Administration (FDA) approved in 2000 as safe and effective for terminating early pregnancies. The questions presented are: 1) whether respondents have Article III standing to challenge FDA's 2016 and 2021 actions; 2) whether FDA's 2016 and 2021 actions were arbitrary and capricious; 3) whether the district court properly granted preliminary relief.
- Subject(s)
- United States. Food and Drug Administration—Trials, litigation, etc
- Alliance for Hippocratic Medicine—Trials, litigation, etc
- Danco Laboratories, L.L.C.—Trials, litigation, etc
- Abortion—Law and legislation—United States—Cases
- Abortion services—United States—Cases
- Reproductive health services—United States—Cases
- Abortifacients—Law and legislation—United States—Cases
- Mifepristone—Law and legislation—United States—Cases
- Women's rights—United States—Cases
- Genre(s)
- Note
- "Nos. 23-235, 23-236."
- Bibliography Note
- "Table of authorities": Pages ii-xii.
Includes bibliographical references.
View MARC record | catkey: 45893071